{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6q2sgJDA","lastupdate":"2023-09-06T00:00:00.000Z","update_date":"2023-09-06T00:00:00.000Z","lastModified":"Mar 18, 2025","active":1,"confidence_score":91,"confidence_score_reason":"funding rounds, markets, not claimed","urlname":"b-cure-laser","minimal_profile":null,"status":"Public","fullstatus":"Public on TASE on May, 2021<br>","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$NBCMdULJI2D35GpVQ05jNaRc9wreYSbPSr9UAaZ0ND3rPEbZMKuwiC","name":"B-Cure Laser","oneliner":"Low-level Laser Therapy Device for Home Use","registrar":"514034123","website":"https://bcurelaser.com/","careerspage":"","founded_month":10,"founded_year":2007,"formernames":["Erika Carmel"],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCX_SjzgH-Ry-a9LYySEgd5A","facebook":"https://www.facebook.com/Israel.Bcure.Laser/?brand_redir=233371063773289","linkedin":"https://www.linkedin.com/company/2897909","instagram":""},"social":["https://www.youtube.com/channel/UCX_SjzgH-Ry-a9LYySEgd5A","https://play.google.com/store/apps/details?id=com.makeree.bcure&hl=en_US","https://www.linkedin.com/company/2897909","https://www.facebook.com/Israel.Bcure.Laser/?brand_redir=233371063773289"],"flattenedsociallinks":"https://www.youtube.com/channel/UCX_SjzgH-Ry-a9LYySEgd5A|https://play.google.com/store/apps/details?id=com.makeree.bcure&hl=en_US|https://www.linkedin.com/company/2897909|https://www.facebook.com/Israel.Bcure.Laser/?brand_redir=233371063773289","apps":{"appstore":"","googleplay":"https://play.google.com/store/apps/details?id=com.makeree.bcure&hl=en_US"},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":29,"patent":1,"raised":25500000,"stage":"Public","public_stage":"Public","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Erika Carmel","B Cure","Good Energies","Erika B-Cure Laser"],"about":"B-Cure Laser offers a line of products providing clinical low-level laser power in a light, portable, rechargeable, and user-friendly medical device. The device is designed for the rapid, noninvasive, and efficient treatment of pain, orthopedic conditions, wounds, burns and skin problems, inflammation, and sports injuries. \n\nThe company's products utilize class-one lasers and are sold over the counter. B-Cure Laser products are marketed and distributed by Good Energies Ltd.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972737293001","country":null,"address":{"israeli":[{"id":"03558455-7981-4d90-80ed-5fd4a001310b","city":"Tirat Carmel","type":null,"address":"Nahum Het Street 5, Haifa, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"North District","news":[{"id":"0Vx5JH2rQ9GdGtp4kfXqbj5hzwwSGwnG9aZPa3ZPE53iWMyE4yM0g9","date":"Mar 11, 2024","link":"https://www.themarker.com/markets/2024-03-11/ty-article/.highlight/0000018e-28f6-dbcf-abee-39fe38200000?utm_source=mailchimp&utm_medium=Content&utm_campaign=markets&utm_content=9097107f5a","source":"www.themarker.com","visible":1,"analysis":{"tags":"Management Changes","company":"אריקה בי קיור","layoffs":"N/A","summary":"The company אריקה בי קיור, controlled by Michael and Tzipora Shloser, is set to hold a stockholders meeting next week. Among the agenda items, the company proposes to grant Chairman Yaki Vadmani a salary package of 920,000 shekels, and the new CEO Ronen Goldstein a salary package of about 1.57 million shekels. The company, which was traded at a value of 1.5 billion shekels, is sold for only 17 million shekels.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":8,"key_topics":"Salary Package, Stockholders Meeting, Company Valuation","date_of_event":"March 11, 2024","valuation_amount":"1.5 billion shekels","impact_on_company":"Neutral","investment_amount":"N/A","structured_issues":"Management Changes","acquisition_amount":"17 million shekels","structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"none;"},"sentiment":"Neutral","analysisId":"I3NQWMQEBtnfwcVohVjMlRxEWRwYttBgJXoTiubXs27JSPCe32ygpL","news_summary":"המניה קרסה ב-96%, והיו\"ר רוצה חבילת שכר של כמעט מיליון שקל על חצי משרה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"tMvNOrvIcKlH6ntmF31xtCiMlFtSQsDA6poqMvx8q557fw5nID8sJC","date":"Feb 13, 2024","link":"https://www.themarker.com/markets/2024-02-13/ty-article/.premium/0000018d-a36c-d42f-adcd-ebecb3b10000?utm_source=mailchimp&utm_medium=Content&utm_campaign=markets&utm_content=69052a3faf","source":"www.themarker.com","visible":1,"analysis":{"tags":"Regulatory Issues","company":"אריקה בי קיור","layoffs":"N/A","summary":"The Israeli Securities Authority has begun enforcement proceedings against Erika Biocure following the companys report that it had received regulatory approval from the European Union for some of its products, when in fact it did not have such approval.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":7,"key_topics":"Regulatory Approval, Misrepresentation","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-negative","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"0zdGSjyvWySZWPpWkYZdHkdkuGRQofd103gDaempadTC6NoABa6B1M","news_summary":"פרשת האישורים באירופה: רשות ני\"ע פותחת בבדיקה בחברת אריקה בי קיור","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"aSUjxtULOMwnbMpKMJ8305XEi4dXplxiBmcoekaz4VBijQinWGo1Xq","date":"Dec 18, 2022","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2328143_0_Txtetaxjxdshwhus8sp&did=1001433052","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Management Changes","company":"B-Cure Laser","layoffs":null,"summary":"B-Cure Laser, an Israeli medical equipment company, has appointed Gideon Landsberger as its new CEO. This follows the dismissal of the previous CEO, Dr. Rom Eliaz, after only six months due to what the company described as his unsuitability for the role and a crisis of confidence. Landsberger previously served as CEO of Remedia, a baby food marketing company, and Apron Machines. B-Cure Laser, which was established in 2007, has seen its stock price fall by more than 90% since its IPO in 2021. The company also reported a 53% decrease in revenue in the first half of 2022, and a loss of 25.5 million shekels.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["New CEO","Company Crisis","Stock Decline","Revenue Decline","Cash Burn"],"date_of_event":"Not specified","valuation_amount":"23 million shekels","impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"nYY0q45CcS4xEertmU3HCzQq5Zjs6qwwFffZIpNrzfldDx156GMXJq","news_summary":"גלובס זירת העסקים של ישראל","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0nDfBlwZJd5LTSq6i3wqXOy4q5zus98Q41kd25oOUTofyL0S4Fp2Ik","date":"Dec 11, 2022","link":"https://www.globes.co.il/news/article.aspx?did=1001432405","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Management Changes, Layoffs","company":"B-Cure Laser","layoffs":"N/A","summary":"B-Cure Laser, an Israeli medical equipment company, has dismissed its CEO, Dr. Rom Eliaz, after only six months in the role. The company cited a lack of fit for the role and a crisis of trust as reasons for the dismissal. B-Cure Laser, which was established in 2007, has seen a dramatic decline in its share price, losing 96% of its value since its IPO last year. The company has also reported a 53% drop in revenue in the first half of 2022 and a loss of 25.5 million shekels. The companys financial situation remains uncertain, with only 35 million shekels in cash remaining.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":8,"key_topics":["CEO Dismissal","Company Crisis","Revenue Decline","Financial Loss","Market Failure"],"date_of_event":"N/A","valuation_amount":"Less than 20 million shekels","impact_on_company":"growth-negative","investment_amount":"N/A","structured_issues":["Management Changes","Layoffs"],"acquisition_amount":"N/A","structuredIssuesShow":"#Management Changes  #Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"GRCkVwCaohxy35kQwPnI2dzanGf0kQ0hiDJUSW3zJgg2O96m6hw6YS","news_summary":"\"משבר אמון\": בי־קיור לייזר פיטרה את המנכ\"ל לאחר חצי שנה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Gy8Kw4JDX2KFwOmPq9OvAn7v3vwoB8ratumqW2FpEtUdsHVsrkSPme","date":"Oct 2, 2022","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2286496_0_Txtetaxjxdshwhus8sp&did=1001425963","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Management Changes, Layoffs","company":"אריקה בי־קיור","layoffs":"45 employees","summary":"Israeli company Arikha Bi-Cure, developer of the Bi-Cure Laser pain treatment device, has been experiencing a sharp decline in both revenue and share price in recent months. Two external directors have resigned, stating they no longer feel they can contribute to the company. The companys current valuation is 27 million shekels, after a 97% drop in share price since the beginning of the year. The company has also reduced its workforce from 150 employees in January 2022 to approximately 105. Arikha Bi-Cure is also facing a class-action lawsuit for 115 million shekels for misleading revenue forecasts.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Resignation","Financial Decline","Layoffs","Lawsuit","Product Failure"],"date_of_event":"Not specified","valuation_amount":"27 million shekels","impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Management Changes","Layoffs"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes  #Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"TtlrToLev1yI9GA64OlyXo2izVcR1CQqHoPHX9Qm5sHaaMsSf9tfyx","news_summary":"גלובס זירת העסקים של ישראל","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"oUmYQZHP001sdu4FAA1QntHYzVfzz2IYPcMJiJx9CmPjqr1ehfsRqx","date":"Sep 12, 2022","link":"https://en.globes.co.il/en/article-the-rise-and-fall-of-b-cure-laser-1001424143","source":"en.globes.co.il","visible":1,"analysis":{"tags":"consumer health, medical device, IPO, lawsuit","company":"Erika B-Cure Laser","layoffs":"30%","summary":"Erika B-Cure Laser, a medical device company, has experienced a significant decline in its business and share price. The company went public at half the valuation it originally sought and raised about NIS 110 million from the public. However, the share price has collapsed, losing about 95% to date. Erika B-Cure Laser is now traded at a market cap of only NIS 35 million. The company is also facing a NIS 115 million lawsuit over a misleading detail in its prospectus. The lawsuit claims that the companys forecast revenue for 2021 was far from reality. Erika B-Cure Laser attributes its sales decline to changes in the digital sector, privacy policies, and the end of COVID-19 restrictions. The company plans to implement efficiency measures, including reducing its workforce by 30%.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Erika B-Cure Laser","IPO","financial performance","market conditions","sales decline"],"date_of_event":"2022-09-12","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Public Trading","Management Changes","Layoffs"],"acquisition_amount":null,"structuredIssuesShow":"#Public Trading  #Management Changes  #Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"01zLXMNAm40x0VBreEdpF4LMvVDulKDd4qKhnwRRo6Xgw1ZZ0cZbJn","news_summary":"The rise and fall of B-Cure Laser","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ei66O1DntLAOkxZRclf2a1bLcoJeRYbjojidd3nRS0aXuIkbOuS8mS","date":"Aug 31, 2022","link":"https://www.calcalist.co.il/market/article/by5tj11akj?_atscid=7_134353_204082920_2258408_0_Txtetaxjxdshwhus8sp","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"Financial Loss, Layoffs","company":"אריקה בי־קיור לייזר","layoffs":"30%","summary":"אריקה בי־קיור לייזר, a company that markets a laser device for pain treatment, has reported a 47% drop in sales for the first half of 2022, resulting in an operational loss of 23.6 million shekels. The company attributes the decline to customers returning to clinics for treatment post-COVID-19 and difficulties in collecting payments from customers in England. The company has also undergone management changes and laid off 30% of its workforce as part of a recovery plan.","partners":null,"customers":"Customers in England","investors":null,"confidence":9,"key_topics":["Sales Decline","Management Changes","Layoffs","Financial Loss","Market Changes"],"date_of_event":"First half of 2022","valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Customers","Layoffs","Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Layoffs  #Management Changes","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"RIvwet5v64PJ9HH7kvtZNrrhYBVqugEPrsmwEN7ulqyCMcc6M8jM9L","news_summary":"https://www.calcalist.co.il/market/article/by5tj11akj?_atscid=7_134353_204082920_2258408_0_Txtetaxjxdshwhus8sp","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dc6b9e21-58d8-4cb8-b7fb-3f4615a1dec1","date":"Jun 19, 2022","link":"https://www.calcalist.co.il/market/article/h1nexi3t9?_atscid=7_134353_204082920_2220766_0_Txtetaxjxdshwhus8sp","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"declining sales","company":"בי-קיור לייזר","layoffs":null,"summary":"בי-קיור לייזר, a company that sells products for pain relief, has experienced a significant decline in sales and expects a 45% decrease in revenue compared to 2021. The company also anticipates significant operational losses due to rising advertising prices. As a result, the company has initiated a cost-cutting plan, including potential layoffs and other measures to improve financial results. The company attributes the sales decline to advertising price increases and changes in privacy policies in its digital advertising channels. Despite having a cash balance of approximately 36 million shekels, the company expects a substantial decrease in sales in the coming months. Several senior executives have resigned, and the companys owner has appointed a new CEO. The company plans to implement additional cost-cutting measures and reduce marketing expenses.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["sales decline","advertising prices","business model","cost-cutting measures","management changes"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Customers","Investment","Management Changes","Layoffs"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment  #Management Changes  #Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"fDqkmhyhQSBmSiV1c7ARNhzJlX4JDcC8CfcowuPxu0j4metkFSM9zw","news_summary":"בי-קיור לייזר צופה ירידה חדה בהכנסות והפסד תפעולי של 17 מיליון שקל  כלכליסט","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0f7eb5c7-2494-4198-ade1-ddd8b24fc36c","date":"Jun 8, 2022","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2213948_0_Txtetaxjxdshwhus8sp&did=1001414370","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Management Changes, Layoffs","company":"אריקה בי-קיור","layoffs":"Multiple senior roles","summary":"The medical equipment company, Arikha Biocure, has recently experienced a sharp decline in its stock due to missed forecasts and a shift to loss. This has been accompanied by a wave of senior resignations, including the CEO, CFO, and several other key roles. The companys owner, Miki Shloser, has stated that they are currently hiring a new international marketing director and believes the company is moving in the right direction. Arikha Biocure, which develops and markets a medical device for pain treatment, has also recently acquired the distribution rights for a new product from another company owned by Shloser.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Management Changes","Layoffs","Stock Decline","Revenue Shortfall","New Product"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Management Changes","Layoffs"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes  #Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"DyntX4Ta0j3p0SIhTDncFxtxydk9G1gb6b9e9x5rPwrzHy4ez9PUVJ","news_summary":"אחרי שהמניה נחתכה, המנהלים הבכירים בבי-קיור לייזר נוטשים  בלעדי","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"16e19189-2f44-4226-bc17-dd42b4d989d7","date":"May 10, 2022","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2195920_0_Txtetaxjxdshwhus8sp&did=1001411328","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Management Changes, Layoffs","company":"אריקה בי-קיור","layoffs":"CEO and CFO resigned","summary":"Arikha Bi-Cure Laser, a medical device company, has seen a significant decline in its stock price, with a 60% contraction since its initial public offering. The companys CEO, Motti Nevon, has resigned, following the resignation of the CFO and International Operations Manager, Nir Barb, last month. The company, which developed and markets a medical device for pain treatment, was initially valued at 800 million shekels during its IPO on the Tel Aviv Stock Exchange last year. However, the companys value has now dropped to around 200 million shekels. The companys founder, Miki Shloser, currently holds about 74% of its shares.","partners":"Not mentioned","customers":"Not mentioned","investors":"Motti Nevon","confidence":8,"key_topics":["Management Changes","Revenue Decline","Stock Price Decline","New Product","Stakeholder Investment"],"date_of_event":"Not mentioned","valuation_amount":"200 million shekels","impact_on_company":"growth-negative","investment_amount":"Not mentioned","structured_issues":["Management Changes"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"FcPSGEbnoaz7FHI68yxGGL5BGMTkX49CmK4Y9NwvmzuTjm8p11EJFe","news_summary":"מי ירפא את כאב המשקיעים? בי-קיור לייזר ממשיכה לשקוע","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e21f21a2-0e36-45b4-a4e6-075cbc9f9e1f","date":"Oct 26, 2021","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_2000922_0_Txtetaxjxdshwhus8sp&ArticleId=106676&from=hp","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"medical devices","company":"אריקה כרמל","layoffs":null,"summary":"Arika Carmel has received approval from the Canadian Ministry of Health to market and sell its laser-based medical device, Bi-Cure Laser, in Canada. The company plans to start marketing and selling the product in November. This approval signifies the growing global demand for pain treatment and orthopedic solutions. Arika Carmel already has approvals in the UK, where sales account for about 25% of the companys total sales, and has submitted an application to the FDA in the US. The company is also in the process of seeking regulatory approval in China. Arika Carmel went public on the Tel Aviv Stock Exchange in August, raising approximately 108 million NIS.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["medical devices","laser therapy","healthcare","global markets","regulatory approvals"],"date_of_event":null,"valuation_amount":"700 million NIS","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"bcC3jvZhcF0hu096FkeiOrEAVC6WDoHUBXSZsvzNIy9HzVWdl69Nbj","news_summary":"אריקה כרמל המייצרת את מכשיר הבי-קיור לייזר קיבלה אישור ממשרד הבריאות הקנדי","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"33020f77-8a9d-473e-bee0-1a030adc232f","date":"Jul 22, 2021","link":"https://en.globes.co.il/en/article-b-cure-laser-developer-halves-ipo-valuation-1001379215","source":"en.globes.co.il","visible":1,"analysis":{"tags":"IPO, valuation","company":"Erika Carmel","layoffs":null,"summary":"Erika Carmel, a developer and marketer of pain relieving medical device B Cure Laser, has revised its IPO prospectus, cutting its valuation from NIS 800 million to NIS 430 million. The company plans to raise nearly NIS 90 million, while existing shareholders will sell holdings worth NIS 20 million. The decrease in valuation is attributed to the market becoming more selective. The decline in the number of players and recent acquisitions in the market have made it tougher for offerings to proceed. Large institutions have the power to bring down the price. The article was published on July 22, 2021.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["IPO","Valuation","Market Selectivity","Acquisitions","Institutional Investors"],"date_of_event":"2021-07-22","valuation_amount":"NIS 430 million","impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Public Trading","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"yLn7E28dEHFdpvSHthKreO4UrPdTKcNv71ApznOPXMnrQezXQip8y7","news_summary":"B Cure Laser developer halves IPO valuation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"54107d45-04df-44cb-909b-02de3ea1c0ce","date":"May 19, 2021","link":"https://www.themarker.com/markets/.premium-1.9822260?_atscid=7_134353_204082920_1875453_0_Txtetaxjxdshwhus8sp","source":"www.themarker.com","visible":1,"analysis":{"tags":"Public Trading","company":"B-Cure Laser","layoffs":null,"summary":"B-Cure Laser, a company that produces medical devices for pain and orthopedic treatment, is planning to go public on the Tel Aviv Stock Exchange. The company, led by founder and chairman Miki Shloser, is looking to raise between 200-250 million shekels at a valuation of around 1 billion shekels. The aim of the IPO is to expand the companys operations abroad.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["IPO","B-Cure Laser","Medical Devices","Orthopedic Treatment","Pain Management"],"date_of_event":"19 May 2021","valuation_amount":"1 billion shekels","impact_on_company":"growth-positive","investment_amount":"200-250 million shekels","structured_issues":["Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gR3EB84KzkCWapLxYpNC9KtLuYVKaoUVnqZrLjaVJPSbQ6BCX8ddhg","news_summary":"בי-קיור לייזר מגיעה לבורסה: תנפיק לפי שווי של מיליארד שקל","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"956d6161-68e8-4f59-a453-b1f446c7db1c","date":"Jul 15, 2015","link":"http://www.jpost.com/Israel-News/Culture/Testin-Lab-No-more-pain-409071","source":"www.jpost.com","visible":1,"analysis":{"tags":"healthcare, medical device","company":"Erika Carmel Ltd.","layoffs":null,"summary":"The article discusses the B-Cure Laser, a soft laser home treatment device developed by Israeli company Erika Carmel Ltd. The device effectively treats pain and orthopedic problems such as back pain, neck and knee pain, and tennis elbow. It harnesses the power of large and expensive laser machines found in pain clinics, producing similar results using a small hand-held device. The B-Cure Laser encourages the bodys natural healing powers, invigorates blood flow, releases endorphins, and reduces inflammation. The device is lightweight, easy to operate, and safe. It is already present in over 10,000 Israeli homes and is also used in hospitals. The article highlights positive testimonials from patients and recommends the device for athletes and sports injuries. The B-Cure Laser is approved by the Health Ministry.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["soft laser technology","pain treatment","home medical device","endorphins","natural healing"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"8rWuBs9AzKq8OpIe0RwJrJzgyrkDU6Lpg7dft6DWUHfnnSDz1hLDgP","news_summary":"http://www.jpost.com/Israel-News/Culture/Testin-Lab-No-more-pain-409071","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8eb469f2-0b17-4ef9-9ee5-1192ff912c9d","date":"Jun 13, 2012","link":"http://www.israelnationalnews.com/News/News.aspx/156823","source":"www.israelnationalnews.com","visible":1,"analysis":{"tags":"medical device","company":"B-Cure Laser","layoffs":null,"summary":"The article discusses B-Cure Laser, an Israeli invention that provides clinical soft laser therapy in a portable and user-friendly medical device. It is the first portable soft laser device with the healing power of a full-sized machine used in hospitals. B-Cure Laser uses low-level laser technology to treat pain, wounds, burns, sports injuries, inflammation, acne, and skin rejuvenation. The device is rechargeable and can be used at home, providing effective and unlimited treatments. The article highlights the growth-positive impact of B-Cure Laser, as it expands its customer base and offers a convenient solution for pain management and treatment.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["B-Cure Laser","soft laser therapy","portable device","treatment of pain","rechargeable"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YqMqKCuzX58K8MleBYjqWPS4S2gLvJXl3aSOm12WBB3GK3x0eulLvv","news_summary":"Israeli B-Cure Laser Cures Your Pain Right at Home","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":15,"techcommunityinvolvement":null,"mediagallery":[{"id":"d54cf2bf-b836-4fce-a747-1c9fdad0173b","timestamp":"2020-05-10 10:50:11.000000","resources_type":2,"resources_title":"B-Cure Laser","resources_file_name":"opCKLEgV4nE","alt":"B-Cure Laser logo","imageurl":"https://img.youtube.com/vi/opCKLEgV4nE/0.jpg","url":"http://youtu.be/opCKLEgV4nE"},{"id":"90a1494a-caec-45f5-879f-842d5fbd9b9d","timestamp":"2018-06-17 11:59:16.000000","resources_type":2,"resources_title":"Promo","resources_file_name":"nzaK-Ie3bZ4","alt":"Promo logo","imageurl":"https://img.youtube.com/vi/nzaK-Ie3bZ4/0.jpg","url":"http://youtu.be/nzaK-Ie3bZ4"}],"tags":["skin","non-invasive","orthopedics","therapeutics","lasers","home-care","burns","medical-devices","skin-care","pain-relief","athletes","seniors","clinics","healthcare-providers","sports","dental","anti-inflammatory","infection","patients","hospitals","optronics","medical-technologies","treatments"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-u8oJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2C","B2B"],"productstage":"Released","products":["B-Cure Dental Laser Pro","B-Cure Dental Laser","B-Cure Laser","B-Cure Laser Sport","B-Cure Laser Pro","B-CURE STAND","B-Cure Laser Sport Pro"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":4841029,"marketcapitaldate":"2025-10-01T13:03:26.000Z","funding":{"investors":0,"lastfunding":"$25.5M","totalrounds":1,"fundingstage":"Public","totalfunding":"$25.5M","publicinvestors":0,"lastpublicfunding":25500000,"totalpublicrounds":1,"totalpublicfunding":25500000},"team":[{"name":"Aviram  Cohen","email":"aviram@bcurelaser.com","phone":"","gender":"Male","userid":"VOK6uYAELOSzyh8ZbmmIfJeE7BjUPKo8yVK9ZNXkaiwb4o7HUx1Hka","bounced":true,"claimed":null,"founder":0,"urlname":"aviram-cohen","visible":1,"memberid":"8fUQQGDToUhn67iU4WgNNFpyIwFRfLwSvP0fKDvonwdzCS5R28maIN","position":"CFO","last_name":"Cohen","claimtoken":null,"first_name":"Aviram ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/aviram-cohen-0482157/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"AC","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Itay Avni","email":"itay@bcurelaser.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4J6n0pAKDA","bounced":false,"claimed":0,"founder":0,"urlname":"itay-avni-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg3sm40gkM","position":"Head of Global Sales and BD","last_name":"Avni","claimtoken":"u23LxQ0cho7X2mBErJUD3hHZlLicKMohwiStzZOHEuoPcuDXjOixOl","first_name":"Itay","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/itay-avni-510a5251/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-09-06 09:35:37.000000","initials":"IA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shlomi Elcobi","email":"shlomi@gd-energies.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4PynhMMLDA","bounced":true,"claimed":0,"founder":0,"urlname":"shlomi-elcobi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg_M2WrQkM","position":"Sales Manager","last_name":"Elcobi","claimtoken":"7259e19455fc23d59047ab33864bdb7e9350bb1119b913a9440d824b0f5bf2d1","first_name":"Shlomi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/%D7%A9%D7%9C%D7%95%D7%9E%D7%99-%D7%90%D7%9C%D7%A7%D7%95%D7%91%D7%99-22ab40113/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2019-08-04 14:01:46.000000","initials":"SE","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2020-05-26T00:00:00.000Z","crunchbaseid":"good-energies-2","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":"Rebecca Mack","creator_email":"rebeccamack26@gmail.com","createdate":"2014-07-17T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"4ItQAht0t88s0AaqfmD7BYQJBVJmU9QUoyoSIU3CN4UxWph3j5KJfm","date":"May 2021","amount":"Undisclosed","source":"https://time.news/the-collapse-continues-b-cure-laser-cuts-the-forecast-for-2022/","ticker":"BCUR.TA","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$25.5M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":25500000,"valuationnumber":null}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"10/2007","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"B-Cure Laser","logourl":"https://storage.googleapis.com/clean-finder-353810/$NBCMdULJI2D35GpVQ05jNaRc9wreYSbPSr9UAaZ0ND3rPEbZMKuwiC","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$NBCMdULJI2D35GpVQ05jNaRc9wreYSbPSr9UAaZ0ND3rPEbZMKuwiC","seoabout":"B-Cure Laser offers a line of products providing clinical low-level laser power in a light, portable, rechargeable, and user-friendly medical device. The d...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Laser","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Recreational & Lifestyle","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Fitness & Sports","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-u8oJDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA>Laser#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA>Fitness & Sports#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-u8oJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|2:>TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA/Laser#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA/Fitness & Sports#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-u8oJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Patients","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]},{"title":"Consumers","key":"0-1","path":"IndustryClassificationModel>Consumers","children":[{"title":"Demographics & Family","key":"0-1-0","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Seniors","key":"0-1-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Seniors"}]},{"title":"Recreational & Lifestyle","key":"0-1-1","path":"IndustryClassificationModel>Consumers>Recreational & Lifestyle","children":[{"title":"Fitness & Sports","key":"0-1-1-0","path":"IndustryClassificationModel>Consumers>Recreational & Lifestyle>Fitness & Sports"}]}]}],"coreTechnology":[{"title":"Sensing","key":"0-0","path":"TechnologyClassificationModel>Sensing","children":[{"title":"Laser","key":"0-0-0","path":"TechnologyClassificationModel>Sensing>Laser"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Laser","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Recreational & Lifestyle","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Fitness & Sports","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-u8oJDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Sensing","Laser"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Patients","Consumers","Demographics & Family","Seniors","Recreational & Lifestyle","Fitness & Sports"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"4ItQAht0t88s0AaqfmD7BYQJBVJmU9QUoyoSIU3CN4UxWph3j5KJfm","date":"May 2021","amount":"Undisclosed","source":"https://time.news/the-collapse-continues-b-cure-laser-cuts-the-forecast-for-2022/","ticker":"BCUR.TA","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"$25.5M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":25500000,"valuationnumber":null}],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}